INTRODUCTION
Several different processes may lead to agammaglobulinemia in animals and in man. Although most congenital immunodeficiencies have been related to an inherent lymphocyte differentiation arrest, aberrant immunoregulatory mechanisms have been implicated in acquired agammaglobulinemia (1) (2) (3) (4) (5) (6) . It has been shown that a subset of T cells is responsible for the suppression of gammaglobulin secretion by normal B cells (1, (3) (4) (5) (6) . In some instances, in vitro removal of suppressor cells resulted in reestablishment ofgammaglobulin secretion (1, (3) (4) (5) (6) . However, similar in vivo manipulations of suppressor cells, including treatment with cytotoxic drugs and steroids (1, 4) , did not reverse the state ofagammaglobulinemia, suggesting that much form 1 August 1980. 42 remained to be learned about immunoregulatory processes in man. The initial immunological aberration in our patient was an autoantibody to the TH2-helper T cell subset (7), followed several years later by suppressor T cells characterized as being TH2+, Ia+ cells (6) . We report here the characterization of the antihelper T cell antibody and the changes in the T cell phenotype that resulted from various therapeutic interventions.
Case report. D.L. was a 17-yr-old white male with no family history of immunodeficiency or autoimmune diseases. Two of his three healthy siblings were HLA B and D identical with him. Recurrent infections started in the patient in the 1st yr of life with conjunctivitis, dacrocystitis, rhinitis, and otitis media, causing a progressive hearing loss. Frequent episodes ofbronchitis and bronchopneumonias appeared at 3 yr, soon followed by diffuse bronchiectasis. However, childhood illnesses including measles, mumps, and varicella between the ages of6-8 yr were uneventful. Moreover, immunizations with diphtheria, tetanus, and pertussis as well as with live oral polio vaccine at 1-4 yr caused no adverse reactions. Only smallpox vaccination at 4 yr caused a severe localized reaction, with ulceration persisting for several weeks. Agammaglobulinemia was diagnosed at 7 yr, and regular prophylactic treatment with gammaglobulin was instituted at 8 yr. Skin tests for delayed-type hypersensitivity were positive, and in vitro mitogenic responses of lymphocytes to phytohemagglutinin (PHA)' were normal. Growth and weight proceeded along the third percentile until 10 yr, but came to a complete halt at age 13.
The patient was followed at the Albert Einstein College of Medicine from the age of 11 . At 15 yr a sudden deterioration occurred, hallmarked by progressive interstitial pneumonitis with respiratory failure, malabsorption (lactose intolerance), recurrent parotitis, epileptic seizures, and a rapidly spreading erythematous and exfoliative maculopapular rash. On biopsy, the skin lesion consisted of an infiltrate with atypical blastlike lymphocytes, some of which had visible nucleoli. At this time, suppressor T cells were first noted and later on identified as TH2+Ia+ cells (6) .
Transfusions of fresh-frozen radiated plasma and injection ofthymosin fraction V (Hoffman-La Roche; Nutley, N. J.) failed to alter the downhill course. The same applied to an 8-wk course of biweekly extensive plasmapheresis, each time followed by a transfusion of irradiated fresh-frozen plasma. Although the serum antihelper T cell activity was removed, no clinical change was noted. Attempts to modify the suppressor T cell activity by the use of three daily infusions of up to 20 mg/kg of an anti-TH2+ immunoglobulin (prepared by the Upjohn Co., Kalamazoo, Mich.) and by a 1-mo course of daily 2 mg/kg body wt prednisone were successful, but had no lasting effect, and serum immunoglobulins never increased. A total thymectomy wvas performed o<n 21 March 1979. Within 2 wk after this procedure, the maculopapular skin rash disappeared, and the patient remained afebrile for 5 wk (the longest interval wvithout temperature since 1977).
Moreover, the anorexia and malabsorption disappeared, the dyspnea decreased, and no TH2+Ia+ cells were detectable in the peripheral blood. 2 mo later, however, the initially beneficial response to thymectomy was reversed by the development ofosteomyelitis of the sternum. Although massive antibacterial treatment, drainage of the abscess, and finally a stemotomy temporarily brought the infection under control, the patient progressively lost ground. In September 1979, a bone marrow transplant was attempted as a last resort; shortly after the transplant, however, the patient succumbed to sepsis. Autopsy permission was refused.
METHODS

Serum immunoglobulins
IgA, IgG, IgD, and IgM were measured by radial immunodiffusion, using specific antisera. Peripheral blood lymphocytes (PBL) were isolated on a Ficoll-Hypaque density gradient. Blast transformation after stimulation with PHA, concanavalin A (Con A), pokeweed mitogen (PWNM), Candida, streptodornase-streptokinase staphylococcus A, tetanus toxoid, purified protein derivative, Herpes Zooster, and in the mixed lymphocyte cultures was measured by the incorporation of tritiated thymidine as previously reported (8) . T cells were detected by rosetting with sheep erythrocytes (SRBC). Rosettes were read in a fluorescence microscope after staining with euchrvsin (8) . Complement receptor positive lymphocytes were counted by rosetting with SRBC coated with Forssnian rabbit anti-SRBC serum and mouse complement (8) . Surface immunoglobulin on lymphocytes was detected by rhodamine-conjugated F(ab')2 antisera to human immunoglobulins according to Preud'homme and Labaume (9) . TH2', TH2-, and Ia' lymphocytes wvere counted on the fluorescenceactivated cell sorter (FACS II).
In brief, isolated T cells were incubated with a horse antiserum to T cells, or with a rabbit anti-p23,30 serum to detect Ialike antigens (6) . The cells were then washed and reacted with fluorescein isothiocyanate (FITC)-conjugated F(ab')2 rabbit anti-horse IgG, or with FITC-goat IgG fraction anti-rabbit IgG as developer for the anti-Ia serum. FACS analysis was performed as described previously (6, 10 Mass.) and the radioactivity on the filter paper monitored. Precipitation with normal rabbit serum was used as a control and the counts subtracted from those obtained with rabbit anti-kappa antiserum. Suppressor cells were also identified by the reverse plaque assay as previously reported (6) .
Nature of the lymphocytotoxic serum factor
In most experiments, patient's serum was used. In some, an IgG serum fraction was studied. The IgG-enriched fraction was obtained by ammonium sulfate precipitation followed by fractionation on a G-200 Sephadex column, and by separation of the IgG fraction by DE-52 ion-exchange chromatography.
The obtained IgG fraction was extensively concentrated (up to 300 mg% of IgG) to obtain a T cell reactivity identical to that of native serum with IgG levels of -50 mg%. The used serum or its IgG fractions were free of aggregates as measured by the Raji cell assay, according to Theofilopoulos, and did not react with Fc receptors of T cells, as suggested by the lack of inhibition of TF,V and TFC, rosettes (8) after preincubation of T cells with the patient's serum or its IgG fraction. Lymphocytotoxicity ofpatient's serum. A pellet of 1 x 106 peripheral blood lymphocytes or 1 x 10c T cells isolated by rosetting with SRBC was incubated for 1 h at 370 or at 4°C with 0.2 ml of patient's serum. Next, the cells were washed three times in RPMI and incubated with guinea pig complement for an additional 2-18 h at 37°C. Cell killing was evaluated by two different techniques: (a) trypan blue dye exclusion according to James et al. (13) , and (b) 5'Cr-micro cytotoxicity assay according to Brunner et al. (14) . Percent cytotoxicity was calculated according to the formula: (5'Cr released by experiment) -(5'Cr released spontaneously) (51Cr released by freeze-thaw)
-(51Cr released spontaneously)
x 100 = % cytotoxicity. Patient's serum in the absence of added guinea complement, normal human AB serum, and guinea pig complement alone were used as controls. Values of > 15% cytotoxicity were considered significant.
Effect of patient's serum on blast transformation to nonspecific mitogens (PHA, Con A), to specific mitogens (Candida, purified protein derivative), and to allogeneic cells (MLC Effect of patient's serum on helper T cells. The in vitro secretion ofimmunoglobulin kappa chains (IgK) by B cells was studied as mentioned above (see suppressor cell assay). To assess helper T cell activity, co-cultures ofB cells were conducted with 1,000 rad-irradiated T cells to eliminate suppressor cells by the method of Siegal and Siegal (17) . Co-cultured irradiated and nonirradiated T cells were preincubated for 2-18 h with guinea pig complement in the presence or absence of patient's serum or with the purified autoantibody.
Binding of patient's serum to enriched T cell populations. (Table I) ; all TH2+ cells were Ia positive as previously reported (6) .
In vitro lymphocyte blast transformation in response to nonspecific mitogens and to specific antigens was first tested at 8 yr. Since 12 yr these tests were performed 6-14 times yearly. The responses were practically absent only in the last 2 yr of the patient's life. (Fig. 1) . TH2+ cells diminished (7%) most significantly after thymectomy (see also Fig. 2 ; 5/31/79 was 70 d after thymectomy). However, 71 d after surgery the percentage of TH2+ cells abruptly returned to its original high levels (Fig. 2: 6/1/79, 42%; 6/4/79, 65%). The suppression of allogeneic B cells by patient's T cells disappeared after hydrocortisone treatment as well as after total thymectomy. It did not recur even after TH2+Ia+ cells reappeared 71 d after thymectomy. On the other hand, the suppression of histoidentical B cells remained unchanged after thymectomy and after hydrocortisone treatment. On only one occasion after treatment with the TH2+ antiserum did this suppression disappear (6) . However, at no time was an in vivo increase of gammaglobulin levels noted. After plasmapheresis, the activity of the lymphocytotoxic autoantibody dimin- ished (Table VII and VIII) , and a rapid increase oftotal lymphocytes and T cell counts up to 4.2-fold over the preplasmapheresis level was noted. The autoantibody remained unchanged or even increased during treatments with an anti-TH2+ serum or hydrocortisone, and after thymectomy (Table VIII) .
DISCUSSION
Most patients with acquired agammaglobulinemia probably have an intrinsic B cell defect. In some, suppression of B cell differentiation by T cells was considered an important pathogenetic mechanism (1, (3) (4) (5) (6) . However, manipulation of suppressor T cells has at most reconstituted B cell function in vitro (1, 4) , and many patients with acquired agammaglobulinemia who had nonfunctional circulating B cells lacked detectable suppressor T cells (1) (2) (3) (4) (5) . Consequently, regulatory factors other than suppressor T cells may have been involved in these patients. Indeed, the lack of a factor responsible for B cell maturation was reported in a patient with thymoma and hypogammaglobulinemia (18, 19) , whereas in other instances a serum factor inhibiting in vitro gammaglobulin secretions was documented (20) . Such inhibitory factors may exert their influence by virtue oftheir lymphocytotoxicity, as has been postulated in patients with episodic lymphopenia and immunologic amnesia (21) . Lymphocytotoxins have been identified in a variety of disorders directly or indirectly related to the immune system, such as systemic lupus erythematosus (22, 23) , juvenile rheumatoid arthritis (22, 24) , infectious mononucleosis, and after live rubella virus vaccine (25) . We have reported a non-HLA lymphocytotoxic factor in a patient with acquired agammaglobulinemia. This factor peaked during an episode of acute graft-vs.-host reaction (26) . The nature of this antibody and its specificity could not be further defined. However, Tursz et al. (27) identified in a patient with hypogammaglobulinemia a factor that turned out to be an autoantibody to B cells, and in their patient, a dramatic increase in B cells occurred after plasmapheresis (27) . In the patient presented here, the detected autoantibody reacted with a subset of T cells, but not with B cells.
Our patient's serum or its IgG fraction not only bound to T cells (Table VII) , but killed a subset of T cells in the presence of complement (Table IV) . This subset was further characterized by the use ofheteroantisera to human T cells. It has been recently shown that the fluorescence pattern of T cells reacted with these FITCconjugated heteroantisera is bimodal when analyzed on the FACS (10) . 80% of T cells show low intensity and are termed TH2-, whereas 20% demonstrate high fluorescence intensity and are termed TH2+. Human suppressor T cells are found in the TH2+ population, whereas helper cells are TH2 (10, 28, 29) . The lymphocytotoxic antibody from our patient's serum reacted with the TH2-subset (Table VIII) . Furthermore, TH2-cells that were reacted with the lymphocytotoxic factor could be rosetted out with erythrocytes coated with an anti-human IgG (Fig. 1) .
Several observations clearly indicated that this autoantibody played a central causative, if not the primary role in the development of agammaglobulinemia in our patient. First, the TH2-subset, with which the autoantibody reacted in vitro, was also diminished in vivo. Second, functions mainly related to the TH2-subset (6, 10, 24) such as mitogenic responses to antigens, PHA, Con A, and allogeneic cells were abolished in vitro and in vivo by the autoantibody (Tables I and V) . Third, irradiation of patient's T cells to obtain a functional helper T cell population freed of the concommitantly existing suppressor T cells (17) failed to provide help for gammaglobulin secretion by normal B cells (not shown). This finding further supported the hypothesis that not only were the helper T cells diminished numerically by the antibody, but they were also deficient functionally. Fourth, normal irradiated T cells, when preincubated with the patient's serum or autoantibody in the presence of complement, lost their previously intact helper function (Table VI) . Fifth, plasmapheresis resulted in an increase of TH2-cells in the peripheral blood and in a several-fold increase in total lymphocyte and T cell numbers. Moreover, after plasmapheresis, irradiated patient's T cells regained some of their helper potential for gammaglobulin secretion by autologous B cells.
In addition to the autoantibody to TH2-cells, our patient was also noted to have an abnormal TH2' cell population. The percentage ofTH2+ cells was markedly increased, and most of these cells were activated, as indicated by the presence of the Ia+ marker (6). Moreover, the in vitro secretion of gammaglobulin was abolished when normal lymphocytes were co-cultured with the patient's T cells (Table III) . The pathogenetic role of the T-suppressor cells vs. the autoantibody to helper T cells could, by and large, be clarified by the temporal analysis ofboth phenomena. Initially the autoantibody alone was detectable, whereas late in the course of the disease both existed side by side. In fact, the autoantibody preceded by several years the detection of suppressor cells by the PWM assay. The appearance of detectable suppressor cells coincided with a rapid decay of cell-mediated immunity and with a clinical deterioration evinced by progressive pulmonary failure, malabsorption, and a skin rash consisting of extensive infiltrates with blastlike lymphocytes. The relationship of this symptomatology to the suppressor cells was further supported by its reversal during treatments aimed against the suppressor cells. Introduction of an anti-TH2+ serum and the administration of steroids treatment (29) , as well as total thymectomy, each caused a regression of the skin rash and the dyspnea and the disappearance ofthe symptomatology related to the malabsorption syndrome.
Taken together, the above data suggested that the suppressor cells were a secondary phenomenon in this patient. It became also apparent, however, that the clearance of the autoantibody by plasmapheresis could be of benefit for the patient only if combined with a permanent reduction ofthe suppressor cell population. Because steroids and the use of an anti-TH2+ serum failed to induce a long-lasting and appropriate control of the suppressor T cells, we resorted to a total thymectomy to achieve this goal.
Several studies in humans and in animals suggested that thymectomy may reduce the suppressor cell subset. In mice the maturational impulse for the suppressor cells bearing the Ly2,3 surface marker, the corrolary of the TH2+ cells in humans, is provided by the intrathymic environment. Thymectomy in mice results in the loss of functional Ly2,3 cells (30) . In humans, thymectomy may lead to a decay of cellmediated immunity (31) and to de novo autoimmune diseases such as myasthenia gravis and lupus erythematosus (32, 33) ; in both diseases a suppressor T cell defect was documented (34, 35) . Conversely, thymomas may be accompanied by an abundance of suppressor T cells and acquired agammaglobulinemia (12) . Our patient had an enlarged thymic shadow on tomography. After total thymectomy a gradual decline of TH2+ cells to normal values was noted (Fig. 2, 5/31/79 ). TH2+Ia+ cells were also not detectable at that time. Concommitantly, the patient's T cells lost their suppression for allogeneic, but not for histoidentical B cells (29) . This finding suggested that a small but potent suppressor cell subset, which could not be identified on the FACS by its TH2 and Ia phenotype, may have persisted. Moreover, 71 d after thymectomy, the TH2+Ia+ subset reemerged, probably because of infection (Fig. 2 , 6/1 and 6/4/79); it was functionally different from the prethymectomy TH2+Ia+ subset. Namely, after thymectomy the patient's T cells did not regain their suppressor effect on allogeneic 13 cells. The lack of allogeneic B cell suppression after thymectomy may be related to the absence of the thymic microenvironment, as has been suggested in thymectomized and congenitally athymic (nude) mice (30) . In such mice, a variety ofsubstances that increase intracellular cyclic AMP levels were capable of producing changes in prothymocytes similar to the thymus itself. Those changes included the expression of Ly markers, which seem to be the analogue of the TH2 markers in humans. These generated cells were endowed only with a moderate response to Con A and a minimal allogeneic response, however. It was thus postulated that in the absence of the thymus, the T cell precursor goes into a pathway of differentiation that generates nonfunctional T cells (30) . The same hypothesis may apply to the post-thymectomy TH2+Ia+ cells in our patient.
